| 产品描述: | HBV抑制剂;HBV Inhibitors;产品介绍: Besifovir是新型有效的无环核苷膦酸酯,用于治疗HBV感染。;InformationBesifovir Besifovir is novel and potent acyclic nucleotide phosphonate used to treat hepatitis B virus (HBV) infection. |
| 体内研究: |
前药 LB80380 (口服给药; 30、60、120、240 毫克) 会迅速吸收并转化为其母体药物贝西福韦 (LB80331) (在血浆中未检测到 LB80380)。LB80331 的中值 Tmax 范围为给药后 1.0 至 2.0 小时。此后,血浆 LB80331 浓度呈单指数下降,t1/2 的平均值为 2.5~3.3 h。 |
| 参考文献: |
1. Jung JA, et al. Pharmacokinetic comparison of the maleate and free base formulations of LB80380, a novel nucleotide analog, in healthy male volunteers. Int J Clin Pharmacol Ther. 2012 Sep;50(9):657-64. 2. Yuen MF, et al. A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B. Antivir Ther. 2006;11(8):977-83. 3. Lung-Yi Mak, et al. Pharmacokinetic evaluation of besifovir for the treatment of HBV infection. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):101-106. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.342 ml |
16.71 ml |
33.419 ml |
| 5 mM |
0.668 ml |
3.342 ml |
6.684 ml |
| 10 mM |
0.334 ml |
1.671 ml |
3.342 ml |
| 50 mM |
0.067 ml |
0.334 ml |
0.668 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |